EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Apelin‐13 and Galectin‐3 in COVID‐19: Associations With Routine Biochemical Parameters and Diagnostic Performance in a Case–Control Study

İsmail Uğurlu iD

Journal of Clinical Laboratory Analysis · 2026-08 · 40 (15)

DOI: 10.1002/jcla.70284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 19.06.2026. Verfasst von İsmail Uğurlu. Beteiligte Einrichtung: Department of Medical Biochemistry, Faculty of Medicine, Kafkas University, Kars, Türkiye. Hauptthemen laut MEDLINE: Intercellular Signaling Peptides and Proteins, Galectin 3. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Apelin‐13 and Galectin‐3 (Gal‐3) are bioactive mediators linked to inflammation and cardiometabolic pathways. Their clinical utility in COVID‐19 alongside routine laboratory tests remains unclear.

Methods

In this case–control study, 89 adults were enrolled (COVID‐19 negative controls, n = 44; COVID‐19 positive patients confirmed by PCR and/or CT, n = 45). Serum Apelin‐13 and Gal‐3 were measured by ELISA, and routine biochemical parameters were obtained using automated analyzers. Group comparisons and correlation analyses were performed, and receiver operating characteristic (ROC) analysis assessed discriminatory performance.

Results

Compared with controls, the COVID‐19 group showed higher ALT ( p = 0.046), GGT ( p = 0.004), ALP ( p = 0.001), total bilirubin ( p = 0.008), direct bilirubin ( p = 0.001), urea ( p = 0.001), creatinine ( p = 0.001), glucose ( p = 0.001), and CRP ( p = 0.001), and lower eGFR ( p = 0.001), albumin ( p = 0.010), and total cholesterol ( p = 0.021). In controls, Apelin‐13 correlated negatively with urea ( r = −0.333, p = 0.027) and Gal‐3 correlated negatively with cholesterol ( r = −0.342, p = 0.023). In COVID‐19 patients, Apelin‐13 correlated positively with glucose ( r = 0.320, p = 0.032) and negatively with sodium ( r = −0.323, p = 0.030). ROC analysis showed limited diagnostic value for Gal‐3 (AUC = 0.549; p = 0.426) and Apelin‐13 (AUC = 0.533; p = 0.594).

Conclusions

Apelin‐13 and Gal‐3 showed limited associations with selected biochemical alterations in COVID‐19, but neither biomarker demonstrated adequate standalone discriminatory performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intercellular Signaling Peptides and ProteinsGalectin 3HumansCase-Control StudiesFemaleMiddle AgedMaleAdultBiomarkersCOVID-19ROC CurveSARS-CoV-2AgedGalectinsBlood Proteins

Stichwörter der Autor:innen

Apelin‐13COVID‐19Galectin‐3routine laboratory testing

Substanzen

Intercellular Signaling Peptides and ProteinsGalectin 3apelin-13 peptideBiomarkersLGALS3 protein, humanGalectinsBlood Proteins

Autor:innen und Institutionen

  • Department of Medical Biochemistry, Faculty of Medicine, Kafkas University, Kars, Türkiye.

ORCID-Profile: İsmail Uğurlu

Zitieren

APA

Uğurlu, İ. (2026). Serum Apelin‐13 and Galectin‐3 in COVID‐19: Associations With Routine Biochemical Parameters and Diagnostic Performance in a Case–Control Study. Journal of Clinical Laboratory Analysis, 40(15). https://doi.org/10.1002/jcla.70284

Vancouver

Uğurlu İ. Serum Apelin‐13 and Galectin‐3 in COVID‐19: Associations With Routine Biochemical Parameters and Diagnostic Performance in a Case–Control Study. Journal of Clinical Laboratory Analysis. 2026;40(15). doi:10.1002/jcla.70284

BibTeX
@article{Uurlu2026,
  author = {Uğurlu, İsmail},
  title = {Serum Apelin‐13 and Galectin‐3 in COVID‐19: Associations With Routine Biochemical Parameters and Diagnostic Performance in a Case–Control Study},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2026},
  volume = {40},
  number = {15},
  doi = {10.1002/jcla.70284}
}
Kostenlos starten →